[P4–586]: ENHANCED ORAL BIOAVAILABILITY OF EDARAVONE AND REVERSE COGNITIVE DEFICITS IN AN ALZHEIMER'S DISEASE MODEL VIA A SELF‐MICELLIZING SOLID DISPERSION APPROACH. (1st July 2017)